Completely resolved advanced biliary tract cancer after treatment by pembrolizumab: a report of two cases
Completely resolved advanced biliary tract cancer after treatment by pembrolizumab: a report of two cases
复制标题
DOI：
10.2147/ott.s197559
复制
发表时间：
2019-01-01
影响因子：
4
通讯作者：
Obeidat, Khaled A.
中科院分区：
文献类型：
--
作者：
Alshari, Osama M.;Dawaymeh, Tamara A.;Obeidat, Khaled A.
胆道癌（BTC）是一种侵袭性疾病，预后差.吉西他滨联合顺铂是晚期BTC的标准一线姑息治疗。吉西他滨-顺铂治疗进展后尚无既定治疗。在这篇文章中，我们介绍了两例晚期BTC患者，他们接受了pembrolizumab治疗，肿瘤已经完全消退。
Biliary tract cancers (BTC) represent an aggressive disease with a dismal prognosis. Gemcitabine in combination with cisplatin is the standard first-line palliative treatment for advanced BTC. There is no established treatment following progression on gemcitabine-cisplatin. In this article, we present two cases for individuals with advanced BTC who were treated with pembrolizumab and the tumors have completely resolved.